|
Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998. |
|||||||||||||||||||||
Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Earnings Scheduled For November 3, 2025
November 03, 2025
Halozyme (HALO) Q3 2025 Earnings Call Transcript
November 03, 2025
Insights into Halozyme Therapeutics's Upcoming Earnings
October 31, 2025
Koa Wealth Liquidates All 68K IIPR Shares Valued at $3.8 Million
October 29, 2025
The Analyst Verdict: Halozyme Therapeutics In The Eyes Of 10 Experts
October 15, 2025
Forecasting The Future: 7 Analyst Projections For Halozyme Therapeutics
September 22, 2025
Frequently Asked QuestionsIs Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 71.06
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 11/12/25 09:55 AM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 10.12B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|
||||||||||||||||||||
|
|||||||||||||||||||||